Dopamine agonists in Parkinson’s disease

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.11, 2003-11, pp. : 1803-1820

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dopamine D3 Agonists in the Treatment of Parkinson&aposs Disease

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 10, 2015-05 ,pp. : 908-926

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine Agonists in Parkinsons Disease: What is Their Role in Early Treatment?

By Stocchi F.

CNS Drugs, Vol. 10, Iss. 3, 1998-09 ,pp. : 159-170

Adis International

Access to resources Recommend Favorite

Sleep Attacks and Dopamine Agonists for Parkinsons Disease: What is Currently Known?

By Zesiewicz T.A. Hauser R.A.

CNS Drugs, Vol. 17, Iss. 8, 2003-01 ,pp. : 593-600

Adis International

Access to resources Recommend Favorite

Neurotoxins and medicinals for the treatment of Parkinson’s disease. Part 2: dopamine receptors and their agonists

By Kadieva M. Oganesyan É. Mutsueva S.

Pharmaceutical Chemistry Journal, Vol. 39, Iss. 10, 2005-10 ,pp. : 520-532

Springer Publishing Company

Access to resources Recommend Favorite

Dopamine Receptor Agonists for Protection and Repair in Parkinson's Disease

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-08 ,pp. : 1089-1099

Bentham Science Publishers

Access to resources Recommend Favorite